Key points are not available for this paper at this time.
This essay analyzes the subject positioning demanded by randomized control trials (RCT). Taking seriously the fact that people in late-stage cancer treatments will die, even if one arm of the study receives a “successful” treatment, Jain argues that the RCT framework carries a politics belied by its status as an objective research method.
S. Lochlann Jain (Fri,) studied this question.